{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:33:48Z","timestamp":1780378428691,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"S6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00415-008-6020-z","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T14:41:07Z","timestamp":1237473667000},"page":"109-114","source":"Crossref","is-referenced-by-count":27,"title":["Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy"],"prefix":"10.1007","volume":"255","author":[{"given":"Alexander","family":"Winkelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Patejdl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Benecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe Klaus","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"7020_CR1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH, ScheltensP, Campi A, Polman CH, Comi G,Ad\u00e8r HJ, Losseff N, Valk J (1997) Comparisonof MRI criteria at first presentationto predict conversion to clinicallydefinite multiple sclerosis. Brain120:2059\u20132069","journal-title":"Brain"},{"key":"7020_CR2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00415-005-0055-1","volume":"253","author":"Bellesi","year":"2006","unstructured":"Bellesi M, Logullo F, DiBella P, ProvincialiL (2006) CNS demyelination duringanti-tumor necrosis factor alphatherapy. J Neurol 253:668\u2013669","journal-title":"J Neurol"},{"key":"7020_CR3","first-page":"239","volume":"34","author":"Bensouda-Grimaldi","year":"2007","unstructured":"Bensouda-Grimaldi L, Mullemann D,Valat JP, Autret-leca E (2007) Adalimumab-associated Multiple Sclerosis.J Rheumatol 34:239\u2013240","journal-title":"J Rheumatol"},{"key":"7020_CR4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/ard.48.12.971","volume":"48","author":"Calin","year":"1989","unstructured":"Calin A (1989) Is there an associationbetween ankylosing spondylitis andmultiple sclerosis? Ann Rheum Dis48:971\u2013972","journal-title":"Ann Rheum Dis"},{"key":"7020_CR5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s002340100619","volume":"43","author":"Cellerini","year":"2001","unstructured":"Cellerini M, Gabbrielli S, Bongi SM(2001) Cerebral magnetic resonanceimaging in a patient with ankylosingspondylitis and multiple sclerosis-likesyndrome. Neuroradiology 43:1067\u20131069","journal-title":"Neuroradiology"},{"key":"7020_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.mcg.0000155126.82171.32","volume":"39","author":"Enayati","year":"2005","unstructured":"Enayati PJ, Papadakis KA (2005) Associationof anti-tumor necrosis factortherapy with the development ofmultiple sclerosis. J Clin Gastroenterol39:303\u2013306","journal-title":"J Clin Gastroenterol"},{"key":"7020_CR7","first-page":"985","volume":"120","author":"Foroozan","year":"2002","unstructured":"Foroozan R, Buono LM, Sergott RC,Savino PJ (2002) Retrobulbar opticneuritis associated with infliximab.Arch Ophthalmol 120:985\u2013987","journal-title":"Arch Ophthalmol"},{"key":"7020_CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archinte.160.4.437","volume":"160","author":"Fox","year":"2000","unstructured":"Fox DA (2000) Cytokine blockade as anew strategy to treat rheumatoidarthritis. Inhibition of tumor necrosisfactor. Arch Intern Med 160:437\u2013444","journal-title":"Arch Intern Med"},{"key":"7020_CR9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2005.07.042","volume":"129","author":"Gupta","year":"2005","unstructured":"Gupta G, Gelfand JM, Lewis JD (2005)Increased risk for demyelinating diseasesin patients with inflammatorybowel disease. Gastroenterology 129:1117\u20131120","journal-title":"Gastroenterology"},{"key":"7020_CR10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.21289","volume":"62","author":"Hemmer","year":"2007","unstructured":"Hemmer B, Hartung HP (2007)Towards the development of rationaltherapies in multiple sclerosis: What ison the horizon? Ann Neurol 62:314\u2013326","journal-title":"Ann Neurol"},{"key":"7020_CR11","first-page":"1018","volume":"33","author":"Jarand","year":"2006","unstructured":"Jarand J, Zochodne DW, Martin LO,Voll C (2006) Neurological complicationsof infliximab. J Rheumatol 33:1018\u20131020","journal-title":"J Rheumatol"},{"key":"7020_CR12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1179\/016164106X98242","volume":"28","author":"Kelley","year":"2006","unstructured":"Kelley RE (2006) Ischemic demyelination.Neurol Res 28:334\u2013340","journal-title":"Neurol Res"},{"key":"7020_CR13","first-page":"A93","volume":"70","author":"Kim","year":"2008","unstructured":"Kim E, Edgar E, Isenhath S, Blauwelt A,Bourdette D, Whitham R (2008)Successful treatment of pyodermagangrenosum with a TNF-alphablocker in a subject with multiplesclerosis. Neurology 70(Suppl 1):A93","journal-title":"Neurology"},{"key":"7020_CR14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4065\/75.8.802","volume":"75","author":"Kimura","year":"2000","unstructured":"Kimura K, Hunter SF, Thollander MS,Loftus EV Jr, Melton LJ 3rd, O\u2019BrienPC, Rodriguez M, Phillips SF (2000)Concurrence of inflammatory boweldisease and multiple sclerosis. MayoClin Proc 75:802\u2013806","journal-title":"MayoClin Proc"},{"key":"7020_CR15","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s00018-005-5022-6","volume":"62","author":"Kodama","year":"2005","unstructured":"Kodama S, Davis M, Faustmann DL(2005) The therapeutic potential oftumor necrosis factor for autoimmunedisease: a mechanistically basedhypothesis. Cell Mol Lif Sci 62:1850\u20131862","journal-title":"Cell Mol Lif Sci"},{"key":"7020_CR16","first-page":"S134","volume":"22","author":"Magnano","year":"2004","unstructured":"Magnano MD, Robinson WH, GenoveseMC (2004) Demyelination andinhibition of tumor necrosis factor(TNF). Clin Exp Rheumatol 22(5 Suppl35):S134\u2013S140","journal-title":"Clin Exp Rheumatol"},{"key":"7020_CR17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(02)08240-5","volume":"359","author":"Marotte","year":"2002","unstructured":"Marotte H, Charrin JE, Miossec P(2002) Infliximab-induced asepticmeningitis. Lancet 359:1252","journal-title":"Lancet"},{"key":"7020_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G,Goodkin D, Hartung HP, Lublin FD,McFarland HF, Paty DW, Polman CH,Reingold SC, Sandberg-Wollheim M,Sibley W, Thompson A, van den NoortS, Weinshenker BY, Wolinsky JS (2001)Recommended diagnostic criteria formultiple sclerosis: guidelines from theInternational Panel on the diagnosis ofmultiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"7020_CR19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0404.1996.tb00004.x","volume":"93","author":"Midgard","year":"1996","unstructured":"Midgard R, Gr\u00f8nning M, Riise T, Kv\u00e5leG, Nyland H (1996) Multiple sclerosisand chronic inflammatory diseases. Acase-control study. Acta Neurol Scand93:322\u2013328","journal-title":"Acta Neurol Scand"},{"key":"7020_CR20","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR,Oliviero PJ, Sandberg G, Crayton H,Richert JR, Siegel JN (2001) Demyelinationoccuring during anti-tumornecrosis factor alpha therapy forinflammatory arthritides. ArthritisRheum 44:2862\u20132869","journal-title":"ArthritisRheum"},{"key":"7020_CR21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/gut.2006.093294","volume":"55","author":"Quispel","year":"2006","unstructured":"Quispel R, van der Worp HB, PruissenM, Schipper ME, Oldenburg B (2006)Fatal aseptic meningoencephalitisfollowing infliximab treatment for inflammatorybowel disease. Gut 55:1056","journal-title":"Gut"},{"key":"7020_CR22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1474-4422(07)70132-1","volume":"6","author":"Ramagopalan","year":"2007","unstructured":"Ramagopalan SV, Dyment DA, ValdarW, Herrera BM, Criscuoli M, Yee IM,Sadovnick AD, Ebers GC; CanadianCollaborative Study Group (2007)Autoimmune disease in families withmultiple sclerosis: a population-basedstudy. Lancet Neurol 6:604\u2013610","journal-title":"Lancet Neurol"},{"key":"7020_CR23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.166.4.991","volume":"166","author":"Ranges","year":"1987","unstructured":"Ranges GE, Figari IS, Espevik T, PalladinoMA (1987) Inhibition of cytotoxicT cell development by transforminggrowth factor-beta and reversakl byrecombinant tumor necrosis factoralpha. J Exp Med 166:991\u2013999","journal-title":"J Exp Med"},{"key":"7020_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00234-003-0991-3","volume":"45","author":"Reidel","year":"2003","unstructured":"Reidel MA, Stippich C, Heiland S,Storch-Hagenlocher B, Jansen O,H\u00e4hnel S (2003) Differentiation ofmultiple sclerosis plaques, subacutecerebral ischaemic infarcts, focalvasogenic oedema and lesions of subcorticalarteriosclerotic encephalopathyusing magnetisation transfer measurements.Neuroradiology 45:289\u2013294","journal-title":"Neuroradiology"},{"key":"7020_CR25","first-page":"339","volume":"23","author":"Selmaj","year":"1988","unstructured":"Selmaj KW, Raine CS (1988) Tumor necrosisfactor mediates myelin and oligodendrocytedamage in vitro. AnnNeurol 23:339\u2013346","journal-title":"AnnNeurol"},{"key":"7020_CR26","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1212\/WNL.45.6_Suppl_6.S44","volume":"45","author":"Selmaj","year":"1995","unstructured":"Selmaj KW, Raine CS (1995) Experimentalautoimmune encephalomyelitis:immunotherapy with anti-tumornecrosis factor antibodies and solubletumor necrosis factor receptors. Neurology45(Suppl 6):S44\u2013S49","journal-title":"Neurology"},{"key":"7020_CR27","doi-asserted-by":"crossref","first-page":"i94","DOI":"10.1136\/ard.59.suppl_1.i94","volume":"59","author":"Selmaj","year":"2000","unstructured":"Selmaj KW (2000) Tumour necrosisfactor and anti-tumour necrosis factorapproach to inflammatory demyelinatingdiseases of the central nervous system.Ann Rheum Dis 59(Suppl I):i94\u2013i102","journal-title":"Ann Rheum Dis"},{"key":"7020_CR28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","volume":"54","author":"Shin","year":"2006","unstructured":"Shin IS, Baer AN, Kwon HJ, PapadopoulosEJ, Siegel JN (2006) Guillain-Barr\u00e9 and Miller Fisher syndromesoccurring with tumor necrosis factoralpha antogonist therapy. ArthritisRheum 54:1429\u20131434","journal-title":"ArthritisRheum"},{"key":"7020_CR29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","volume":"57","author":"Sicotte","year":"2001","unstructured":"Sicotte NL, Voskuhl RR (2001) Onset ofmultiple sclerosis associated with anti-TNF therapy. Neurology 57:1885\u20131888","journal-title":"Neurology"},{"key":"7020_CR30","first-page":"169","volume":"104","author":"Tan","year":"2004","unstructured":"Tan FU, Tellio\u011flu S, Aydin G,Erdemo\u011flu AK, Keles\u00b8 I (2004) Ankylosingspondylitis and multiple sclerosisin a HLA-B27 negative patient. ActaNeurol Belg 104:169\u2013172","journal-title":"ActaNeurol Belg"},{"key":"7020_CR31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-005-0097-x","volume":"25","author":"Tanno","year":"2006","unstructured":"Tanno M, Nakamura I, Kobayashi S,Kurihara K, Ito K (2006) New-onsetdemyelination induced by infliximabtherapy in two rheumatoid arthritispatients. Clin Rheumatol 25:929\u2013933","journal-title":"Clin Rheumatol"},{"key":"7020_CR32","doi-asserted-by":"crossref","unstructured":"The Lenercept Multiple Sclerosis StudyGroup and the University of BritishColumbia MS\/MRI Analysis Group(1999) TNF neutralization in multiplesclerosis: results of a randomized,placebo-controlled multicenter study.Neurology 53:457\u2013465","DOI":"10.1212\/WNL.53.3.457"},{"key":"7020_CR33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00054725-200401000-00004","volume":"10","author":"Thomas","year":"2004","unstructured":"Thomas CW Jr, Weinshenker BG, SandbornWJ (2004) Demyelination duringanti-tumor necrosis factor alpha therapywith infliximab for Crohn\u2019s disease.Inflamm Bowel Dis 10:28\u201331","journal-title":"Inflamm Bowel Dis"},{"key":"7020_CR34","first-page":"1548","volume":"26","author":"Titelbaum","year":"2005","unstructured":"Titelbaum DS, Degenhardt A, KinkelRP (2005) Anti-tumor necrosis factoralpha-associated Multiple Sclerosis.Am J Neuroradiol 26:1548\u20131550","journal-title":"Am J Neuroradiol"},{"key":"7020_CR35","first-page":"1027","volume":"33","author":"Toussirot","year":"2006","unstructured":"Toussirot E, Pertuiset E, Martin A,Melac-Ducamp S, Alcalay M, Grardel B,Seror P, Perdriger A, Wendling D,Mulleman D, Beraneck L, Mariette X;Club Rheumatismes et Inflammation(2006) Association of rheumatoidarthritis with multiple sclerosis: reportof 14 cases and discussion of its significance.J Rheumatol 33:1027\u20131028","journal-title":"J Rheumatol"},{"key":"7020_CR36","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","volume":"47","author":"Van Oosten","year":"1996","unstructured":"Van Oosten BW, Barkhof F, Truyen L,Boringa JB, Berteslmann FW, vonBolmberg BM, Woody JN, Hartung HP,Polman CH (1996) Increased MRIactivity and immune activation in twomultiple sclerosis patients treated withthe monoclonal anti-tumor necrosisfactor antibody cA2. Neurology 47:1531\u20131534","journal-title":"Neurology"},{"key":"7020_CR37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.140.2.531","volume":"140","author":"Yokota","year":"1988","unstructured":"Yokota S, Geppert TD, Lipsky PI (1988)Enhancement of antigen-and mitogen-inducedhuman T lymphocyte proliferationby tumor necrosis factor.J Immunol 140:531\u2013538","journal-title":"J Immunol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-6020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-6020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-6020-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T14:40:22Z","timestamp":1684939222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-6020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":37,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["7020"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-6020-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}